| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970214A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970211A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 01/12/2000 | EP0970210A1 Methods of modulating p33ing1 mediated apoptosis |
| 01/12/2000 | EP0970209A1 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970206A1 Lage-1 tumor associated nucleic acids |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970204A1 Novel gene encoding male-transplantation antigen |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970202A2 Characterization of the yeast transcriptome |
| 01/12/2000 | EP0970200A2 Method for enhancing expression of a foreign or endogenous gene product in plants |
| 01/12/2000 | EP0970199A1 Fluorescent protein sensors for detection of analytes |
| 01/12/2000 | EP0970198A2 Novel compounds |
| 01/12/2000 | EP0970194A2 Method of cell surface activation and inhibition |
| 01/12/2000 | EP0970187A1 Pituitary differentiation factor and methods of use thereof |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970185A1 Insecticidal protein toxins from $i(photorhabdus) |
| 01/12/2000 | EP0970124A2 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 01/12/2000 | EP0970123A2 GENOMIC SEQUENCE OF THE HUMAN $g(m)-OPIOID RECEPTOR GENE AND THE VARIANTS, POLYMORPHISMS AND MUTATIONS THEREOF |
| 01/12/2000 | EP0970122A1 Human anion channel |
| 01/12/2000 | EP0970121A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 01/12/2000 | EP0970120A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 01/12/2000 | EP0970119A1 Synaptic activation protein compositions and method |
| 01/12/2000 | EP0970116A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970114A1 Neoglycoproteins |
| 01/12/2000 | EP0970113A1 Novel monomer elements for marking peptidic nucleic acids |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970110A1 87 human secreted proteins |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970106A1 uPAR MIMICKING PEPTIDE |
| 01/12/2000 | EP0970102A1 Antisense inhibition of angiogenin expression |
| 01/12/2000 | EP0970101A2 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
| 01/12/2000 | EP0969873A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969863A1 Viral defective interfering particles and uses thereof |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0969854A1 Inhibition of signal transduction by the binding of non-phosphorylated compositions |
| 01/12/2000 | EP0969852A1 Combination therapy for the treatment of diabetes and obesity |
| 01/12/2000 | EP0969851A1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 01/12/2000 | EP0969726A1 Treatment for dutch elm disease |
| 01/12/2000 | EP0969714A1 Rg nucleic acids for conferring disease resistance to plants |
| 01/12/2000 | EP0725837B1 Adeno-associated virus - its diagnostic use with early abortion |
| 01/12/2000 | EP0658120B1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241258A VEGF-8/receptor complex and uses thereof |
| 01/12/2000 | CN1241216A Non-mammalian DNA virus having altered coat protein |
| 01/12/2000 | CN1241215A Method of using VIM1 gene to confer disease resistance in plants |
| 01/12/2000 | CN1241214A Microbial preparation of substances from aromatic metabolism/I |
| 01/12/2000 | CN1241213A Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/12/2000 | CN1240830A High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus |
| 01/12/2000 | CN1240829A Optimization method for activation of endogenetic gene of cell |
| 01/12/2000 | CN1240792A Medicine combined by moleculae of growth factor and traumatic factor in gall |
| 01/12/2000 | CN1240670A Simple separating and purifying technique for phytohemagglutinin and its crystal growth |
| 01/12/2000 | CN1048254C Compound for introduction of prospective change in target gene |
| 01/11/2000 | US6013863 Fertile transgenic corn plants |
| 01/11/2000 | US6013862 Wheat aleurone regulatory elements |
| 01/11/2000 | US6013857 Milk produced by a hybrid cattle whose genome comprises a chimeric gene encoding a recombinant heterologous polypeptide that is recovered from milk |
| 01/11/2000 | US6013784 Nucleic acids encoding HST 2 muteins |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013780 VEGF145 expression vectors |
| 01/11/2000 | US6013772 Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays |
| 01/11/2000 | US6013770 Chimeric contraceptive vaccines |
| 01/11/2000 | US6013769 X-linked adrenoleukodystrophy gene and corresponding protein |
| 01/11/2000 | US6013768 Kainate-binding human CNS receptors of the EAA1 family |
| 01/11/2000 | US6013767 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 01/11/2000 | US6013766 Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013764 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
| 01/11/2000 | US6013763 Peptide variants of protein A |
| 01/11/2000 | US6013762 Recombinant non-glycosylated beta tumor cell growth factor; for the diagnosis and treatment of diabetic vision defects, atherosclerosis, and ulcers; wound healing agents; antiproliferative agents |
| 01/11/2000 | US6013658 Animal growth regulators |
| 01/11/2000 | US6013638 Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
| 01/11/2000 | US6013631 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 01/11/2000 | US6013630 Using mutant atrial natriuretic factor proteins, fragments, analogs, derivatives and homologs thereof, the nucleic acids encoding these mutant proteins, and modulators of atrial natriuretic factor for treating or preventing ischemic stroke |
| 01/11/2000 | US6013625 Method and composition for treating thrombosis |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013526 Modified protein for gene transfer and process for producing the same |
| 01/11/2000 | US6013523 Plant cell comprising a pesticidal protein toxin encoded by a synthetic bacillus gene; for plant protection against insect damage; pesticides; insecticides |
| 01/11/2000 | US6013516 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 01/11/2000 | US6013515 Cofactors for HIV-1 protein Tat and methods of use therefor |
| 01/11/2000 | US6013514 Nucleic acid sequence coding for a membrane protein; for treatment diagnosis, dectection, and prevention of infections |
| 01/11/2000 | US6013510 Identification of a DNA region potentially useful for the detection of Mycobacterium kansasii |
| 01/11/2000 | US6013508 Polynucleotide sequence which codes for a protein that confers antibiotic resistance; accurate detection and screening for the presence of gram-positive bacteria resistant to antibiotics, |
| 01/11/2000 | US6013507 Nucleic acid sequences which code for a protein associated with antibiotic resistance in staphylocuccus; for the detection of compounds that can reverse antibiotic resistance |
| 01/11/2000 | US6013506 Vaccination kit for prevention of infection by animal virus; viricides |
| 01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
| 01/11/2000 | US6013503 Mammailian enzymatic fusion protein associated with the urogenital system; for screening of modulators of enzyme activity |